Genetic testing in patients who have had a stroke can be an effective tool in assessing whether clopidogrel is an appropriate treatment to prevent further strokes. This testing is not currently available routinely in the NHS. Following the publication of NICE guidance DG59, NHS England will be piloting genetic testing within stroke services in select sites across England, before it is rolled out across the NHS. The pilot will run from October 2024 to April 2025 and will produce an implementation guide for providers as well as information to support future commissioning decisions.
This online event is for NHS professionals working in stroke units, pharmacy and genomics and who would like to be kept updated on these plans. This webinar will provide more detail on the genetic testing within stroke services pilot, its plans and there’s an opportunity for delegates to ask questions.
For more information on this event, including how to register, please visit its webpage or contact the event’s hosts, the NHS Pharmacogenomics and Medicines Optimisation Network of Excellence.
